APA

Lü W., Yang H., Fan Y., Li T., Zhang L., Mui C., Fan H., Zhou B., Liu Z., Ng H. & Liu X. (20140430). Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients. : Chinese medical journal.

Chicago

Lü Wei, Yang Hai-Hong, Fan Yun-Ming, Li Takming, Zhang Li-Fan, Mui Chongseong, Fan Hong-Wei, Zhou Bao-Tong, Liu Zheng-Yin, Ng Hou and Liu Xiao-Qing. 20140430. Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients. : Chinese medical journal.

Harvard

Lü W., Yang H., Fan Y., Li T., Zhang L., Mui C., Fan H., Zhou B., Liu Z., Ng H. and Liu X. (20140430). Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients. : Chinese medical journal.

MLA

Lü Wei, Yang Hai-Hong, Fan Yun-Ming, Li Takming, Zhang Li-Fan, Mui Chongseong, Fan Hong-Wei, Zhou Bao-Tong, Liu Zheng-Yin, Ng Hou and Liu Xiao-Qing. Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients. : Chinese medical journal. 20140430.